Cutaneous Lymphoma International Consortium

An overview of the Cutaneous Lymphoma International Consortium's (CLIC) work in developing a prognostic index for mycosis fungoides and Sezary Syndrome - the PROCLIPI Study.

Also an overview of the creation of a CLIC Study Biobank to test potential biomarkers in cutaneous lymphoma patients to give clinical information on prognosis and optimal therapy.

A Q&A sessions followed including:
- Where do donated biopsies go? Informed consent when tissues are used in studies.
- Is it possible to participate in the CLIC study?
- Is there a correlation between the incidence of cutaneous lymphoma and other cancers in the same person?
- Is a mathematical model for predicting disease possible?

Presenters: Julia Scarisbrick, MBChB, FRCP, MD, University Hospital Birmingham; Maarten Vermeer, MD, PhD, Leiden University Medical Centre

Recorded at the 2017 2-Day Patient Conference in New York, NY.